ARTICLE | Company News
Thar, Gruenenthal deal
November 18, 2016 9:18 PM UTC
Grünenthal acquired drug formulation company Thar. Thar's Enhance technology is designed to convert IV drugs into oral candidates. Grünenthal plans to conduct Phase III testing of Thar's lead program,...